MedPath

University of Campania Luigi Vanvitelli

University of Campania Luigi Vanvitelli logo
🇮🇹Italy
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.unicampania.it

Clinical Trials

164

Active:4
Completed:104

Trial Phases

5 Phases

Phase 1:4
Phase 2:7
Phase 3:6
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (81 trials with phase data)• Click on a phase to view related trials

Not Applicable
38 (46.9%)
Phase 4
26 (32.1%)
Phase 2
7 (8.6%)
Phase 3
6 (7.4%)
Phase 1
4 (4.9%)

Prospective Study Comparing Two Classification Systems for Second-degree Vaginal Tears During Spontaneous Childbirth to Assess Their Ability to Predict Postpartum Complications.

Not yet recruiting
Conditions
Vaginal Laceration During Delivery
First Posted Date
2025-08-15
Last Posted Date
2025-08-15
Lead Sponsor
University of Campania Luigi Vanvitelli
Target Recruit Count
482
Registration Number
NCT07124676
Locations
🇮🇹

Universita degli studi della Campania "Luigi Vanvitelli" - dipartimento della donna, bambino e chirurgia generale e specialistica,, Naples, Italy

"Sleep Patterns and EEG Structure in Youth With Autism: Links With Behavior and Parental Stress"

Active, not recruiting
Conditions
Sleep Disorder (Disorder)
Autism Spectrum Disorder
First Posted Date
2025-08-14
Last Posted Date
2025-08-14
Lead Sponsor
University of Campania Luigi Vanvitelli
Target Recruit Count
187
Registration Number
NCT07122388
Locations
🇮🇹

University of Campania Luigi Vanvitelli, Napoli, Italy

Screening for Postpartum Depression Using EPDS and HAM-D in Mothers Within 72 Hours After Delivery at a Tertiary Care Center (SOS-Mamma Study)

Not yet recruiting
Conditions
Post Partum Depression
First Posted Date
2025-06-18
Last Posted Date
2025-06-18
Lead Sponsor
University of Campania Luigi Vanvitelli
Target Recruit Count
273
Registration Number
NCT07025902
Locations
🇮🇹

Largo Madonna delle grazie 1, Naples, Italy

The Brain&Senses Study

Not yet recruiting
Conditions
Mild Cognitive Impairment
Alzheimer Disease
Parkinson
First Posted Date
2025-05-28
Last Posted Date
2025-05-28
Lead Sponsor
University of Campania Luigi Vanvitelli
Target Recruit Count
100
Registration Number
NCT06991816
Locations
🇮🇹

Vanvitelli ENT department, Naples, Campania, Italy

Metabolomic Biomarkers Evaluation in Pulmonary Fibrosis

Completed
Conditions
Pulmonary Fibrosis
First Posted Date
2025-05-16
Last Posted Date
2025-05-16
Lead Sponsor
University of Campania Luigi Vanvitelli
Target Recruit Count
59
Registration Number
NCT06974799
Locations
🇮🇹

UOC Clinica Pneumologica L Vanvitelli, Naples, Italy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 33
  • Next

News

Variant Secures EMA Endorsement for VAR002 Gene Therapy Targeting Inherited Retinal Dystrophies

The European Medicines Agency has provided positive scientific advice on Variant's VAR002, an adeno-associated viral vector gene therapy targeting inherited retinal dystrophies linked to CRX mutations.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.